Evidence map›Paper›PMID 30760178›Full record

ArticleJournal of neurotrauma2019

Correlation of Blood Biomarkers and Biomarker Panels with Traumatic Findings on Computed Tomography after Traumatic Brain Injury.

Jussi P Posti, Riikka S K Takala, Linnéa Lagerstedt, Alex M Dickens, Iftakher Hossain, Mehrbod Mohammadian, Henna Ala-Seppälä, Janek Frantzén, Mark van Gils, Peter J Hutchinson and 12 more

Registry-linked trialAbstract read
In one paragraph

Article in Journal of neurotrauma, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06072963 (Combination of Intranasal Insulin With Oral Semaglutide to Improve Cognition and Cerebral Blood Flow), which is not on this map. Cited by 50 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06072963 phase2recruitingstarted 2024, after this paper: background citation

Combination of Intranasal Insulin With Oral Semaglutide to Improve Cognition and Cerebral Blood Flow: a Feasibility Study

Ran2024Enrolled80Registered outcomes15Posted comparisons0ConditionsAlzheimer Disease, Metabolic Syndrome, Mild Cognitive ImpairmentArmsIntranasal insulin, Intranasal insulin placebo, semaglutide, Semaglutide placebo
Open the trial in the graph
3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Accuracy of GFAP and UCH-L1 in predicting brain abnormalities on CT scans after mild traumatic brain injury: a systematic review and meta-analysis.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2025
    Pooled it
  3. The diagnostic and prognostic value of glial fibrillary acidic protein in traumatic brain injury: a systematic review and meta-analysis.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2023
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Blood-based biomarkers GFAP/UCH-L1 for the diagnosis of mild traumatic brain injury (mTBI): a single-center implementation experience.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2026
    Article
  7. Research progress on biomarkers of traumatic brain injury.Animal models and experimental medicine · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Jussi P Posti1 Department of Neurosurgery, Turku University Hospital, Turku, Finland.
Riikka S K Takala2 Turku Brain Injury Center, Turku University Hospital, Turku, Finland.
Linnéa Lagerstedt5 Department of Specialities of Internal Medicine, University of Geneva, Geneva, Switzerland.
Alex M Dickens6 Turku Center for Biotechnology, University of Turku, Turku, Finland.
Iftakher Hossain1 Department of Neurosurgery, Turku University Hospital, Turku, Finland.
Mehrbod Mohammadian2 Turku Brain Injury Center, Turku University Hospital, Turku, Finland.
Henna Ala-Seppälä2 Turku Brain Injury Center, Turku University Hospital, Turku, Finland.
Janek Frantzén1 Department of Neurosurgery, Turku University Hospital, Turku, Finland.
Mark van Gils7 VTT Technical Research Center of Finland Ltd., Tampere, Finland.
Peter J Hutchinson8 Department of Clinical Neurosciences, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.
Ari J Katila2 Turku Brain Injury Center, Turku University Hospital, Turku, Finland.
Henna-Riikka Maanpää1 Department of Neurosurgery, Turku University Hospital, Turku, Finland.
David K Menon9 Division of Anesthesia, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.
Virginia F Newcombe9 Division of Anesthesia, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.
Jussi Tallus2 Turku Brain Injury Center, Turku University Hospital, Turku, Finland.
Kevin Hrusovsky11 Quanterix Corporation, Lexington, Massachusetts.
David H Wilson11 Quanterix Corporation, Lexington, Massachusetts.
Jessica Gill12 National Institute of Nursing Research, National Institutes of Health, Bethesda, Maryland.
Jean-Charles Sanchez5 Department of Specialities of Internal Medicine, University of Geneva, Geneva, Switzerland.
Olli Tenovuo2 Turku Brain Injury Center, Turku University Hospital, Turku, Finland.
Henrik Zetterberg13 Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Kaj Blennow13 Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.

Funding

Department of Health 12/35/57Department of Health HTA/13/15/02Department of Health II-C5-0715-20005Department of Health NIHR-RP-R3-12-013Medical Research Council G0502030Medical Research Council G0600986Medical Research Council G0601025Medical Research Council G1002277Medical Research Council G9439390
6 · The paper itself

Abstract

The aim of the study was to examine the ability of eight protein biomarkers and their combinations in discriminating computed tomography (CT)-negative and CT-positive patients with traumatic brain injury (TBI), utilizing highly sensitive immunoassays in a well-characterized cohort. Blood samples were obtained from 160 patients with acute TBI within 24 h of admission. Levels of β-amyloid isoforms 1-40 (Aβ40) and 1-42 (Aβ42), glial fibrillary acidic protein (GFAP), heart fatty-acid binding protein (H-FABP), interleukin 10 (IL-10), neurofilament light (NF-L), S100 calcium-binding protein B (S100B), and tau were measured. Patients were divided into CT-negative (

Indexed as

AdultAgedBiomarkersBrain Injuries, TraumaticFatty Acid Binding Protein 3FemaleGlial Fibrillary Acidic ProteinHumansInterleukin-10MaleMiddle AgedSensitivity and SpecificityTomography, X-Ray ComputedBiomarkersFABP3 protein, humanFatty Acid Binding Protein 3Glial Fibrillary Acidic ProteinIL10 protein, humanInterleukin-10biomarkerscomputed tomographytraumatic brain injury

Identifiers

PMID30760178
PMCPMC6909751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.